Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2020 3
2021 4
2022 7
2023 6
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine value profile for leishmaniasis.
Kaye PM, Matlashewski G, Mohan S, Le Rutte E, Mondal D, Khamesipour A, Malvolti S. Kaye PM, et al. Among authors: malvolti s. Vaccine. 2023 Nov 3;41 Suppl 2:S153-S175. doi: 10.1016/j.vaccine.2023.01.057. Epub 2023 Oct 6. Vaccine. 2023. PMID: 37951693 Free article.
Overcoming roadblocks in the development of vaccines for leishmaniasis.
Kaye PM, Mohan S, Mantel C, Malhame M, Revill P, Le Rutte E, Parkash V, Layton AM, Lacey CJN, Malvolti S. Kaye PM, et al. Among authors: malvolti s. Expert Rev Vaccines. 2021 Nov;20(11):1419-1430. doi: 10.1080/14760584.2021.1990043. Epub 2021 Nov 2. Expert Rev Vaccines. 2021. PMID: 34727814 Free PMC article. Review.
COVID-19 impact on infant and adolescent vaccine supplies.
Cernuschi T, Malvolti S, Downham M, Maugeais D, Robinson D, Cravioto A. Cernuschi T, et al. Among authors: malvolti s. Science. 2021 Dec 17;374(6574):1438-1441. doi: 10.1126/science.abl7019. Epub 2021 Dec 16. Science. 2021. PMID: 34914520
Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort.
Hanumunthadu B, Kanji N, Owino N, Ferreira Da Silva C, Robinson H, White R, Ferruzzi P, Nakakana U, Canals R, Pollard AJ, Ramasamy M; Vacc-iNTS Consortium. Hanumunthadu B, et al. BMJ Open. 2023 Nov 14;13(11):e072938. doi: 10.1136/bmjopen-2023-072938. BMJ Open. 2023. PMID: 37963701 Free PMC article.
Estimating the future global dose demand for measles-rubella microarray patches.
Ko M, Malvolti S, Cherian T, Mantel C, Biellik R, Jarrahian C, Menozzi-Arnaud M, Amorij JP, Christiansen H, Papania MJ, Meltzer MI, Masresha BG, Pastor D, Durrheim DN, Giersing B, Hasso-Agopsowicz M. Ko M, et al. Among authors: malvolti s. Front Public Health. 2023 Jan 16;10:1037157. doi: 10.3389/fpubh.2022.1037157. eCollection 2022. Front Public Health. 2023. PMID: 36726626 Free PMC article.
23 results